Quality of life and healthcare resource in patients receiving opioids for chronic pain: a review of the place of oxycodone/naloxone
about
Quality of life under oxycodone/naloxone, oxycodone, or morphine treatment for chronic low back pain in routine clinical practice.Effectiveness of the CardioPain initiative in reducing inappropriate NSAID prescriptions in pain therapy among high cardiovascular risk patients: an informative Italian surveyImpact of Treatment with Naloxegol for Opioid-Induced Constipation on Patients' Health State Utility.Treatment of Severe Pain and Opioid-induced Constipation: An Observational Study of Quality of Life, Resource Use, and Costs in Sweden.Peripherally acting μ-opioid receptor antagonists as treatment options for constipation in noncancer pain patients on chronic opioid therapy.Modulation of pain, nociception, and analgesia by the brain reward center.Opioid-Induced Constipation and Bowel Dysfunction: A Clinical Guideline.Definition, diagnosis and treatment strategies for opioid-induced bowel dysfunction-Recommendations of the Nordic Working Group.Oxycodone/Naloxone Prolonged Release: A Review in Severe Chronic Pain.Laxatives Do Not Improve Symptoms of Opioid-Induced Constipation: Results of a Patient Survey.Long-term use of naldemedine in the treatment of opioid-induced constipation in patients with chronic non-cancer pain: a randomized, double-blind, placebo-controlled phase 3 study.Can oliceridine (TRV130), an ideal novel µ receptor G protein pathway selective (µ-GPS) modulator, provide analgesia without opioid-related adverse reactions?Investigational opioid antagonists for treating opioid-induced bowel dysfunction.
P2860
Q36631510-B7B9D427-4599-470A-B9DB-63F499984F77Q37097576-3AB26436-444F-4189-9815-7155D7CFFD3CQ37143758-2F8951AC-9E22-4287-A11B-571E7AF8B0B9Q37459036-29C70B43-460F-489C-BD48-1880261D0953Q37603682-555E09B9-F1C4-4B9A-A27C-848AB905401FQ38836955-91E97B75-1B84-4EA0-A832-12B3F43B9371Q39051851-DD411378-C79A-427D-BD8D-9D1B1CE0551DQ43062741-CA402A0F-EBFB-41CC-B77D-D393008F3F39Q43075620-03721CAF-7EAD-45D4-94D2-D859851E72E9Q44344292-54155CD1-475D-486D-B2BE-4148DA4A356FQ49926308-F01D322F-6427-49DF-B294-183422444811Q52568263-A12D4A7E-F41E-48BD-941F-3997440E04A5Q52740718-C3821F94-F06F-4D7F-8E85-EB50D7F9B5FA
P2860
Quality of life and healthcare resource in patients receiving opioids for chronic pain: a review of the place of oxycodone/naloxone
description
2015 nî lūn-bûn
@nan
2015 թուականի Յունուարին հրատարակուած գիտական յօդուած
@hyw
2015 թվականի հունվարին հրատարակված գիտական հոդված
@hy
2015年の論文
@ja
2015年論文
@yue
2015年論文
@zh-hant
2015年論文
@zh-hk
2015年論文
@zh-mo
2015年論文
@zh-tw
2015年论文
@wuu
name
Quality of life and healthcare ...... he place of oxycodone/naloxone
@ast
Quality of life and healthcare ...... he place of oxycodone/naloxone
@en
Quality of life and healthcare ...... he place of oxycodone/naloxone
@nl
type
label
Quality of life and healthcare ...... he place of oxycodone/naloxone
@ast
Quality of life and healthcare ...... he place of oxycodone/naloxone
@en
Quality of life and healthcare ...... he place of oxycodone/naloxone
@nl
prefLabel
Quality of life and healthcare ...... he place of oxycodone/naloxone
@ast
Quality of life and healthcare ...... he place of oxycodone/naloxone
@en
Quality of life and healthcare ...... he place of oxycodone/naloxone
@nl
P2093
P2860
P921
P1476
Quality of life and healthcare ...... he place of oxycodone/naloxone
@en
P2093
Bart Morlion
Katri Elina Clemens
Will Dunlop
P2860
P356
10.1007/S40261-014-0254-6
P577
2015-01-01T00:00:00Z